Potassium orotate - instructions for use, dose, side effects, contraindications

Stimulates the synthesis of nucleic acids; strengthens reparative and regenerative processes in tissues; has a general stimulating effect on metabolism; enhances the formation of albumin in the liver (especially in prolonged hypoxia). Increases appetite, has a diuretic effect.

Pharmacokinetics:

Absorbed in the gastrointestinal tract (10% of the dose taken). Metabolised in the liver with the formation of orotidin-5-phosphate. It is excreted by the kidneys (30% in the form of various metabolites).

Indications:

Hepatitis, hepatosis, intoxications, anemia, myocardial infarction, myocardial dystrophy, chronic heart failure, chronic physical overstrain.

Contraindications:

Hypersensitivity, cirrhosis, ascites, nephrourolythiasis, renal failure.

Carefully:Pregnancy, lactation.

Pregnancy and lactation:Carefully.

Dosing and Administration:Inside for 1 hour before meals or 4 hours after meals, adults - 500 mg -1.5 g / day in 2-3 divided doses (1 tablet 1-3 times a day). The course of treatment is 20-40 days. If necessary, repeat after 1 month.

Side effects:

Allergic reactions, skin rash, indigestion. In high doses - hepatodystrophy (against the background of a low protein diet).

Interaction:

Astringent and enveloping agents reduce the absorption of orotic acid in the gastrointestinal tract.

Form release / dosage:

Tablets 500 mg.

Packaging:

For 10 tablets in a contour cell or cellulose package.

1, 2 or 6 contour packs, together with instructions for use, are placed in a pack of cardboard.

Contour non-jammed packages with an equal number of instructions for use are placed directly in the group package.

Storage conditions:

Store in a dry place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

4 years. Do not use after the expiration date indicated on the package.

Terms of leave from pharmacies:On prescription

Registration number:LSR-003254/07

Date of registration:17.10.2007

Expiration Date:Unlimited

The owner of the registration certificate:PHARMSTANDART-TOMSKHIMFARM, OJSC PHARMSTANDART-TOMSKHIMFARM, OJSC Russia

Manufacturer: & nbsp

PHARMSTANDART-TOMSKHIMFARM, OJSC Russia

Representation: & nbspPHARMSTANDART JSC PHARMSTANDART JSC Russia

Information update date: & nbsp26.11.2017

Illustrated instructions

Instructions

Potassium orotate (Potassium orotate)